Latest news
We are a clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases
To learn more about Erytech's phase 3 clinical trial in pancreatic cancer
View the webcast of our KOL event on our lead product, eryaspase, in pancreatic cancer with
Dr. Hidalgo and Dr. Noel